BMY FY 2021 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$46.4B+9.1% YoY

Gross Profit

$26.8B57.7% margin

Operating Income

$9.5B20.6% margin

Net Income

$7.0B15.1% margin

EPS (Diluted)

$3.12

Cash Flow

Operating Cash Flow

$16.2B

Free Cash Flow

$15.2B

Stock-Based Comp.

$583M

Balance Sheet

Total Assets

$109.3B

Total Liabilities

$73.3B

Stockholders' Equity

$35.9B

Cash & Equivalents

$14.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46.4B	$42.5B	+9.1%
Gross Profit	$26.8B	$21.7B	+23.3%
Operating Income	$9.5B	$4.5B	+112.4%
Net Income	$7.0B	-$9.0B	+177.8%